| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Common Stock | 10,301,271 | $12,670,563 | $1.23 | 23 Jan 2025 | Direct |
| GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Common Stock | 27,710 | $34,083 | $1.23 | 23 Jan 2025 | By Ed Uihlein Family Foundation |
| GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Stock Option (right to buy) | 60,000 | 23 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | 23 Jan 2025 | 2 | $39,999 | 4 | Director, 10%+ Owner | 27 Jan 2025, 16:09 |
| GALT | GALECTIN THERAPEUTICS INC | 24 Jan 2024 | 2 | $40,000 | 4 | Director, 10%+ Owner | 07 Feb 2024, 16:53 |
| GALT | GALECTIN THERAPEUTICS INC | 26 Sep 2023 | 10 | $10,033,020 | 4 | Director, 10%+ Owner | 27 Sep 2023, 14:03 |
| GALT | GALECTIN THERAPEUTICS INC | 26 Jan 2023 | 2 | $39,999 | 4 | Director, 10%+ Owner | 30 Jan 2023, 15:34 |
| GALT | GALECTIN THERAPEUTICS INC | 24 Jan 2022 | 2 | $35,000 | 4 | Director, 10%+ Owner | 08 Feb 2022, 08:25 |
| GALT | GALECTIN THERAPEUTICS INC | 20 Dec 2021 | 1 | $18,416,210,000,000 | 4 | Director, 10%+ Owner | 25 Jan 2022, 15:29 |
| GALT | GALECTIN THERAPEUTICS INC | 17 Sep 2021 | 1 | $11,574,070,000,000 | 4 | Director, 10%+ Owner | 21 Sep 2021, 16:30 |